Meds.com
Meds.com
Meds.com
Pharmaceutical and technology company focused on providing convenient, affordable, and life-improving drugs to patients.
Pharmaceutical and technology company focused on providing convenient, affordable, and life-improving drugs to patients.
Pharmaceutical and technology company focused on providing convenient, affordable, and life-improving drugs to patients.
Software Development
Software Development
⋅
⋅
Austin
Austin
US
US
⋅
⋅
51–200 employees
51–200 employees
⋅
⋅
Founded:
Founded:
May 2015
May 2015
Overview
Overview
Meds.com owns and operates a handful of businesses in the United States that work together to provide a seamless patient experience that includes education, diagnosis, medical consultation, prescribing, and pharmacy.
With this foundation we are expanding into new drugs, indications, and consumer brands.
Meds.com owns and operates a handful of businesses in the United States that work together to provide a seamless patient experience that includes education, diagnosis, medical consultation, prescribing, and pharmacy.
With this foundation we are expanding into new drugs, indications, and consumer brands.
Employee Growth
Employee Growth
TOTAL EMPLOYEES
TOTAL EMPLOYEES
95
95
6m GROWTH
6m GROWTH
27%
27%
1y GROWTH
1y GROWTH
70%
70%
Department Distribution
Department Distribution
TOTAL EMPLOYEES
TOTAL EMPLOYEES
95
95
Engineering
Engineering
Healthcare Services
Healthcare Services
Human Resources
Human Resources
Operations
Operations
Research
Research
Department Growth
Department Growth
6m GROWTH
6m GROWTH
1y GROWTH
1y GROWTH
Engineering
42%
131%
Healthcare Services
56%
100%
Human Resources
50%
50%
Operations
67%
67%
Research
25%
400%
Web Engagement
pages per visit
pages per visit
1.8
1.8
monthly visits
monthly visits
10,268
10,268
Web Traffic by Country
Web Traffic by Country
United States
100%
United States
100%
Web Traffic Sources
Web Traffic Sources
Direct
39.7%
Direct
39.7%
Search
32.4%
Search
32.4%
Social
6.2%
Social
6.2%
Referrals
10.5%
Referrals
10.5%
AI
1.6%
AI
1.6%
funding round
1
total funding raised
$58.2M
valuation
$99.1M
last round type
IPO
last round amount
$6.8M
announced on
$6.8M
funding round
1
total funding raised
$58.2M
valuation
$99.1M
last round type
IPO
last round amount
$6.8M
announced on
$6.8M
lead investors
lead investors
Ahlström Invest B.V., Cicero Fonder, Lancelot Asset Management, Lupus alpha Asset Management AG, Swedbank Robur, TIND Asset Management
Ahlström Invest B.V., Cicero Fonder, Lancelot Asset Management, Lupus alpha Asset Management AG, Swedbank Robur, TIND Asset Management
Recent News & Articles
Recent News & Articles
A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.
A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.
© 2026 InGrow. All rights reserved.
© 2026 InGrow. All rights reserved.
